In the Literature

In the Literature

In the Literature

TON - May 2017, Vol 10, No 3

Venetoclax plus Rituximab Improves Outcomes in Chronic Lymphocytic Leukemia
Lay Navigation Reduces Medicare Costs, Resource Utilization
Adding Antiandrogen Therapy Improves Survival in Recurrent Prostate Cancer

In the Literature

In the Literature

TON - January 2017, Vol 10, No 1

Gaps in Use of Tyrosine Kinase Inhibitors in Medicare Beneficiaries with Chronic Myeloid Leukemia
Mutations Responsible for Relapse Despite PD-1 Therapy Uncovered in Melanoma
Ricolinostat Shows Promise in Patients with Relapsed or Refractory Multiple Myeloma

In the Literature

In the Literature

TON - November 2016, Vol 9, No 6

Inotuzumab Ozogamicin Shows Benefit in Acute Lymphoblastic Leukemia
Adding Daratumumab to Combination Therapy Improves Progression-Free Survival in Patients with Multiple Myeloma
Enzalutamide Superior to Bicalutamide in Patients with Prostate Cancer

In the Literature

In the Literature

TON - September 2016, Vol 9, No 5

Ixazomib Extends Progression-Free Survival in Multiple Myeloma
Pembrolizumab Shows Potential Antitumor Activity in Advanced Gastric Cancer
ASCO Endorses Canadian Clinical Practice Guideline on Active Surveillance for Localized Prostate Cancer
Delayed Relapses After AntiR11;PD-1 Therapy Linked to Mutation in Patients with Melanoma

In the Literature

In the Literature

TON May 2016 Vol 9 No 3

ASCO Issues Guidelines for Developing Clinical Pathways That Promote Value-Based Care
Second Cancer Risk Is High After Hodgkin Lymphoma
Cancer Screening May Not Save Lives, a New Analysis Suggests

Page 2 of 2

1
2

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

TON Print Edition

TON Weekly e‑Newsletter

I have reviewed and consent to the terms of TON's Privacy Policy, and TON has my permission to retain my information in its database, and to forward pertinent communications to me.